Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies.

Hendriks LEL, Lin JJ, Tan DSW, Acker F, Ogliari FR, Meyer ML, Planchard D, Reck M

Open source

DOI
10.1016/s2213-2600(26)00253-5
Published
2026 Sep 6
Container
The Lancet. Respiratory medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2213-2600-26-00253-5,
  title = {Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies.},
  author = {Hendriks LEL and Lin JJ and Tan DSW and Acker F and Ogliari FR and Meyer ML and Planchard D and Reck M},
  year = {2026},
  journal = {The Lancet. Respiratory medicine},
  doi = {10.1016/s2213-2600(26)00253-5},
  url = {https://doi.org/10.1016/s2213-2600(26)00253-5}
}

RIS

TY  - JOUR
TI  - Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies.
AU  - Hendriks LEL
AU  - Lin JJ
AU  - Tan DSW
AU  - Acker F
AU  - Ogliari FR
AU  - Meyer ML
AU  - Planchard D
AU  - Reck M
PY  - 2026
JO  - The Lancet. Respiratory medicine
DO  - 10.1016/s2213-2600(26)00253-5
UR  - https://doi.org/10.1016/s2213-2600(26)00253-5
ER  - 

APA

LEL, H., JJ, L., DSW, T., F, A., FR, O., ML, M., D, P., & M, R. (2026). Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies.. The Lancet. Respiratory medicine. https://doi.org/10.1016/s2213-2600(26)00253-5

Source records